Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renaissance Acquisition Holdings was a pharmaceutical company and contract development and manufacturing organization (CDMO) specializing in complex dosage forms, including topicals and sterile products. Formed in 2010 by RoundTable Healthcare Partners, the company expanded significantly through the acquisition of DPT Laboratories in 2011. It focused on developing and manufacturing generic prescription and over-the-counter (OTC) products across various therapeutic areas, with a strong emphasis on dermatology. The company operated major facilities in Lakewood, New Jersey, and San Antonio, Texas, providing end-to-end services from formulation development to commercial production. In 2016, Mylan acquired the company's non-sterile topicals business for $950 million to bolster its dermatology portfolio. This acquisition included a diverse pipeline of generic products and established manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renaissance Acquisition Holdings.